BIOC14H3 Lecture Notes - Lecture 9: Gene Gun, Lentivirus, Nortriptyline
1
Lecture 9
find more resources at oneclass.com
find more resources at oneclass.com
2
Lecture 9 Objectives
•Genetic influences on cognitive deficits
•Schizophrenia
•Symptoms and prevalence
•Dopamine hypothesis
•Heritability
•Genetic components
•Autism
•Symptoms, prevalence & heritability
•Genetic and environment components
•Mouse models of autism
•Mood disorders
•Prevalence
•Depression
•Monoamine hypothesis of depression
•SSRIs and serotonin transporters
•Mouse models
Chapter 11: Psychiatric
disorders with a
cognitive component
Chapter 12: Disorders
of Mood, Anxiety and
Personality
find more resources at oneclass.com
find more resources at oneclass.com
3
Lecture 9 Objectives
•Anxiety
•Type of anxiety disorders
•Prevalence
•Diagnostic criteria
•SSRI and anxiety
•Genetic influences
•Genetic counseling
•Tools and analysis
•Gene Therapy
•In vivo and ex vivo
•Techniques
•Examples
•Alzheimer’s disease
•Parkinson’s disease
•Eating behaviour
Chapter 12: Disorders
of Mood, Anxiety and
Personality
Chapter 14: Genetic
counseling,
pharmacogenomics and
gene therapy
find more resources at oneclass.com
find more resources at oneclass.com
Document Summary
Lecture 9 objectives: genetic influences on cognitive deficits, schizophrenia. Symptoms and prevalence: dopamine hypothesis, heritability, genetic components, autism. Symptoms, prevalence & heritability: genetic and environment components, mouse models of autism, mood disorders, prevalence, depression, monoamine hypothesis of depression, mouse models. Chapter 11: psychiatric disorders with a cognitive component. Lecture 9 objectives: anxiety, type of anxiety disorders, prevalence, diagnostic criteria. Ssri and anxiety: genetic influences, genetic counseling, tools and analysis, gene therapy. In vivo and ex vivo: techniques, examples, alzheimer"s disease, parkinson"s disease, eating behaviour. Chapter 14: genetic counseling, pharmacogenomics and gene therapy. Identifying genetic variants by risk allele frequency and strength of genetic effect (odds ratio) 4 very resistant to therapy, people on the street talking to someone thats not there. Symptoms may range from mild (sometimes hardly noticeable) to severe. Schizophrenia: generally similar prevalence country to country with ~0. 5-1% of the population, ~ 24 million people suffered from schizophrenia worldwide with about 280,000 in canada (2011 estimate)